With a history of developing lifesaving medicine for over a century, New Jersey is where discovery happens. Research, talent, funding, available space, university partnerships and industry expertise – New Jersey has it all for life sciences companies.
Home to 13 of the top 20 pharmaceutical companies, you’ll be in good company. A number of industry leaders have found success here, including Celgene (a trailblazer in oncology, acquired by Bristol-Myers Squibb for $74 billion in 2019) and Amicus Therapeutics (which received its first FDA approval for rare diseases in 2018).
We have the brain power to build your business. New Jersey has the largest concentration of scientists and engineers per square mile in the U.S and over 3,200 life sciences companies operating across all sectors. New Jersey is the only state that specializes in four of the five bioscience subsectors.
No matter the size of your company, New Jersey will greet you at every stage of growth. From incubators to stand alone laboratory space at research parks and hubs, you’ll find the support you need here, along with world-class research universities, medical schools and some of the best hospitals in the country.
Source: Bureau of Labor Statistics,
Occupational Employment & Wages, May 2018
Per square mile in the U.S.
Source: JobsEQ, December 2019
Source: Pharmaceutical Executive, 2020
Let New Jersey be your gateway to the Northeast. We’re home to 17 Fortune 500 companies and 225 foreign national U.S. headquarters.
Our central location and infrastructure will get you to where you want to go. A location in New Jersey offers easy access to financial markets and regulatory centers. Northern New Jersey is less than 20 minutes away from Manhattan and Washington D.C. is 3 hours away by train. New Jersey is located in the middle of the Boston – New York City – Washington D.C. corridor, one of the world’s most concentrated and affluent markets with 56.5 million residents and $3.75 trillion in economic output.
With the busiest seaport on the East Coast and one of the busiest airports in America, New Jersey moves people and products like no other state. Newark Liberty International Airport and regional airports offer service to 340+ nonstop domestic and 260+ nonstop international destinations.
Diversity is our strength and makes innovation truly possible. We are the fourth most diverse state in the nation with the third-largest foreign-born population.
New Jersey is home to the highest concentration of scientists and engineers per square mile than anywhere else in the U.S. We offer companies an ever-growing pool of STEM talent from our elite research universities—including #1 ranked Princeton University and Big Ten Academic Alliance member Rutgers University—that offer graduate and postgraduate degrees in biomedical and healthcare fields. Our State has the 4th highest share of STEM graduates in the U.S.
From preschool to graduate school, we invest in our students to help us build the foundation for innovation. New Jersey ranks #2 for educating students at every level and is home to High Technology High School in Lincroft—the #1 STEM high school in the country.
Source: Genetic Engineering & Biotechnology News, September 2018
Source: McKinsey, 2019
Source: FDA, 2017
Trust New Jersey to get your product to market. We’re home to 8 of the world’s top 10 companies for R&D productivity, including Johnson & Johnson and Merck & Co.
From lab to shelf, New Jersey’s diverse and expansive life sciences ecosystem has the support, funding and resources needed for success. More than 600 contract research organization (CROs) and contract manufacturing organizations (CMOs) are located here. The New York/New Jersey region ranks #2 for NIH funding.
The concentration of our research hospitals, medical schools and universities, combined with the State’s population density, multicultural diversity and transportation infrastructure makes New Jersey a perfect location for clinical trials. Today, there are more than 11,000 clinical trials in New Jersey.
Our state has one of the highest concentrations of specialized commercialization expertise in the U.S. Nearly 23,000 members of the State’s life sciences cluster are focused on pharmaceutical manufacturing—that’s 3x the national average.
In 2019, companies with a footprint in New Jersey represented 50 percent of all new FDA drug and therapy approvals.
Source: HINJ, PhRMA, January 2020
Source: Business Facilities, July 2020
Source: FDA, 2019
Among the top 3 U.S. life sciences clusters, New Jersey companies are saving lives. There are over 300 drug and pharmaceutical establishments in New Jersey employing nearly 22,000. Pharma powerhouses like Eisai, Novartis, Eli Lilly, J&J and Allergan are leading the way in the treatment and prevention of Alzheimer’s disease while Pfizer, Bristol-Myers Squibb, Merck and Novartis are improving the lives of cancer patients around the world. We are the #1 state for heart and stroke drugs and #2 state for cancer drugs in development.
|17||Johnson & Johnson|
Source: Pharmaceutical Executive, 2020
New Jersey is ranked #2 state for biotech strength and many companies are pioneering patient-centric treatments with cell and gene therapy breakthroughs. The first ever FDA approved CAR-T cell therapy was developed by Novartis in 2017. New Jersey’s higher education institutes are also on the forefront of next-generation therapeutics: New Jersey Institute of Technology (NJIT) is preparing a specialized workforce with a first of its kind professional science master’s degree program and professional graduate certificate in cell and gene therapy. The New Jersey Innovation Institute (NJII) is home to BioCentriq – an industry-facing contract development and manufacturing facility to bring cell and gene therapies to market.
New Jersey’s innovation ecosystem also includes world-class biobanks, like Infinity BiologiX (a spin-out of Rutgers University) and the Coriell Institute of Medical Research.
|3||Bracco Diagnostics, Inc.|
|4||Cancer Genetics, Inc.|
New Jersey is leading the development of innovative medical devices, from neuro-stimulators to robotic assistance and implantable electronic devices. There are nearly 300 medical device firms in New Jersey employing over 13,200. Twelve and of the top 20 medical device companies call New Jersey home.
Strong collaboration between New Jersey’s 43 teaching hospitals, 5 medical schools, and 6 research universities has allowed companies located here to bring disruptive technologies to market. From research to talent recruitment, New Jersey’s nationally ranked healthcare system – including Hackensack Meridian Health, our State’s largest and most comprehensive and integrated health network – stands ready to support the private sector.
Calling all entrepreneurs: it’s easy to test new ideas here. New Jersey’s life sciences incubators offer companies access to both wet and dry labs, as well as a variety of support services, technical assistance, and access to funding and mentoring to help you grow. Our State is also ready to accommodate biotech companies at stand-alone space at research parks, and university-affiliated innovation hubs.
|wdt_ID||Asset Class||New Jersey||California||Massachusetts||North Carolina||New York||Pennsylvania|
|6||Class A Office Space¹||$36.78 (North) $30.44 (Central) $24.67 (South)||$86.31 (San Francisco) $40.23 (Los Angeles) $44.36 (San Diego)||$82.82 (Cambridge)||$32.91 (Charlotte)||$81.59 (Manhattan) $59.18 (Brooklyn)||$29.77 (Philadelphia)|
|7||LAB Space²||$22.28 (Statewide)||$49.21 (San Francisco) $47.28 (San Diego) $17.79 (Los Angeles)||$63.44 (Cambridge)||$23.21 (Raleigh –Durham)||$79.93 (Manhattan)||$28.20 (Philadelphia)|
|8||FLEX Space³||$13.39 (Statewide)||$22.68 (Statewide)||$14.33 (Statewide)||$11.63 (Statewide)||$14.90 (Statewide)||$11.02 (Statewide)|
|9||Industrial Space⁴||$6.77 (North) $7.43 (Central) $6.18 (South)||$19.02 (San Francisco) $10.85 (Los Angeles) $13.28 (San Diego)||$8.41 (Boston)||$4.80 (Charlotte)||$11.07 (Long Island)||$5.83 (Philadelphia)|
Source: Cushman & Wakefield, JLL, Costar, 2020
Fill out the form to learn more about what New Jersey has to offer.
Once the form is complete, you’ll get access to guides for your industry and a representative will contact you with additional details.
New Jersey offers a number of valuable programs for qualified life sciences companies, including
incentives specifically created to support startup and early stage ventures.
This incentive gives biotech companies the ability to sell their net operating tax losses and R&D tax credits.Learn More
Emerging life sciences companies can gain access to angel and venture capital investors.Learn More
Provides refundable tax credits against New Jersey corporation business or gross income tax.Learn More
Provides growth capital to early-stage technology and life sciences companies.Learn More
Provides free rent support for entrepreneurs seeking to operate in collaborative workspaces, while providing workspaces with a competitive advantage and greater value proposition to offer prospective tenants.Learn More
Suite of financing instruments designed to develop, sustain, and grow life sciences and technology businesses in NJ. Emerging life sciences and technology companies are provided growth capital to directly fund uses such as hiring key staff, product marketing & sales.Learn More
Competitively awarded training grants help TLD companies develop industry-specific solutions to workforce challenges.Learn More
We provide customized RFI responses, demographics, detailed market assessments and other complimentary business relocation and expansion services. When your company chooses to grow in New Jersey, we also will help you publicize your good news.
We’ll make your property search seamless, so you find the site that best meets your relocation or expansion needs.
Our public and private partners provide a wide range of services. From higher education research collaboration to regulatory and legal assistance to workforce training, they’ll ensure you have a smooth landing.